AMANDA STROUD: Open Payments
NPI 1104218247 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 30 payments from 15 companies in 2025. Trend: 2023 $401 · 2024 $776 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| ABBVIE INC. | 3 | $78 |
| Lilly USA, LLC | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Novo Nordisk Inc | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Alkermes, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Exact Sciences Corporation | 1 | $27 |
Products named: CAPLYTA, VRAYLAR, SHINGRIX, SPRAVATO, JARDIANCE, ABILIFY MAINTENA, ARISTADA, Auvelity.
Industry payments across IL — which companies pay providers there.
